Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Summary Report/Recommendations
This report offers recommendations for the care of pregnant women and children following the COVID-19 pandemic. It analyzes health impacts on pregnant women and young children, including those related to health care and childcare, using a socioecological approach. Recommendations include expanding reimbursement and telemedicine access, making childcare accessible and affordable, and integrating equity considerations into data collection and research.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
Article outlines how an opioid treatment program in the Bronx, NY adjusted their clinical practice with COVID-19 and their recommendations for treatment programs going forward. Balancing Covid-19 safety and the need to safely administer medications for opioid use disorder, this program ultimately made changes that allowed for more patient-driven treatment plans that enable fewer in person clinic visits. The article advocates for patient-centered care that encourages people to safely self-manage medication, focusing on patient-centered measures in clinical decision-making, and making appropriate changes to payment/insurance models that allow for such patient-centered care.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
In this report, the National Vaccine Advisory Committee (NVAC) discusses maternal immunizations best practices, as well as gaps to implementation recommendations. One recommendation includes focusing efforts to improve financing for immunization services during pregnancy and the postpartum period. Public health and health care partners can support efforts promoting new payment and delivery models, patient-centered medical homes, and accountable care organizations. NVAC also recommends partnering with professional organizations and other maternal immunization stakeholders to develop toolkits and guidance for improving processes.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report highlights the efficacy of COVID-19 mRNA vaccines (2-dose series) for pregnant mothers and their infants. In the aftermath of the Delta and Omicron waves, infants born to unvaccinated mothers were more likely to be among those hospitalized for COVID-19.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Summary Report/Recommendations
This resources summarizes the impact of the COVID-19 pandemic on substance use and the experiences of people who used drugs during the COVID-19 pandemic. Highlights include: the pandemic increased the risk of overdose for people who use drugs, and in response people who use drugs reported using more harm reduction strategies. The pandemic also motivated change in wanting to quit drug use for study participants, but also highlighted the social determinants of health as barriers to sustainable recovery.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Summary Report/Recommendations
This commentary describes racial disparities in access to medication assisted treatment (MAT) for opioid use disorder (OUD) and how pandemic-related changes in access to MAT may exacerbate these disparities. The author also provides specific recommendations, including actions that can be taken by local health departments to reduce race-based inequities in access to MAT during the pandemic.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article focuses on post-pandemic treatment for individuals with substance use disorder. Specifically, this article identifies seven pillars to improve treatment for individuals with substance use disorders in the wake of the COVID-19 pandemic: (1) telemedicine and digital solutions, (2) hospitalization at home, (3) consultation-liaison psychiatric and addiction services, (4) harm-reduction facilities, (5) person-centered care, (6) promote paid work to improve quality of life in people with substance use disorders, and (7) integrated addiction care. The three “best buys” of the World Health Organization (reduce availability, increase prices, and a ban on advertising) are still valid. Additionally, new strategies must be implemented to systematically deal with (a) fake news concerning legal and illegal drugs and (b) controversial scientific information.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article discusses the preliminary data regarding Syringe Services Program (SSP) operational and service delivery changes during the response to the COVID-19 pandemic and provides key policy and service provision implications for SSPs. There is an emphasis on the distribution of services provided at SSPs and highlights the need for SSP support in providing education, prevention, and strategies to avoid emerging infectious disease outbreaks.